MedWorm: Cancer & Oncology Podcasts

Angelina Jolie and the Power of the Informed Decision

Medscape Oncology — Fri, 17 May 2013 14:07:15 +0100

Dr. Kathy Miller comments on the importance of genetic testing in women at high risk for breast cancer so that they can make personal, informed decisions about their care, as Angelina Jolie has done. (Source: Medscape Oncology)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

STEAM VALVE: SELF EXPRESSION & EMPOWERED SURVIVORS - May 21,2013

The Stupid Cancer Show - Blog Talk Radio — Tue, 14 May 2013 16:15:00 +0100

Cancer sucks any way you slice it but be careful what you wish for when you take to the Internet to rant, rave and share your journey with the universe. Tonight we welcome young adult cancer survivors, writers, bloggers and soap-box e-activists Loni Horn (@lanisia), Jody Schoger (@jodyms) and Eamonn Conrad (@eamonndc) to share the secrets to their success of balancing angst with truth and self expression. Stupid Cancer Chief Chica Officer Erica Reyes in the survivor spotlight!healthcare blogging | empowered patients | young adult cancer | stupid cancer | personal empowerment (Source: The Stupid Cancer Show - Blog Talk Radio)

Breakthrough Drug, Immunotherapy and Targeted Therapies Improving Melanoma Outcomes

Oncology Tube — Tue, 14 May 2013 14:11:18 +0100

In the past few years, research findings and resulting treatment improvements have more than doubled the life expectancy of patients with metastatic melanoma. Medical oncologist, Dr. Jade Homsi of Ban... Author: patientpower Added: 05/14/2013 (Source: Oncology Tube)

COMEDIAN H. ALAN SCOTT + SIBLINGS MATTER! - May 14,2013

The Stupid Cancer Show - Blog Talk Radio — Tue, 14 May 2013 00:00:00 +0100

Tonight were joined by Suzanne Skala (Executive Director, SuperSibs), Melanie Goldish (Founder, SuperSibs) and Whitney Kvistad (Masters of Nursing Grad Student) to disuss the unique and unmet needs of siblings in the cancer journey, significantly in childhood, adolescence and young adulthood. Also, live in-studio, writer/comedian and testicular cancer suvivor H. Alan Scott.cancer caregivers | siblings and cancer | h alan scott | stupid cancer | young adult cancer (Source: The Stupid Cancer Show - Blog Talk Radio)

The Importance of a Medical Oncologist

Oncology Tube — Sun, 12 May 2013 22:08:31 +0100

Dr. William Oh, Chief of Hematology and Medical Oncology, at Mount Sinai Medical Center (NY), speaks on the importance for a patient to consult with a medical oncologist while in the process of treatm... Author: vhsimons Added: 05/12/2013 (Source: Oncology Tube)

Active Surveillance Protocol

Oncology Tube — Sun, 12 May 2013 21:36:39 +0100

Dr. David Shin, of Hackensack University Medical Center (NJ), discusses the key points of an Active Surveillance protocol to maximize treatment efficacy and patient benefit. Author: vhsimons Added: 05/12/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

TWiV 232: Gophers go viral

This Week in Virology - MP3 Edition — Sun, 12 May 2013 18:21:16 +0100

Hosts: Vincent Racaniello, Roberto Cattaneo, Reuben Harris, Lou Mansky, and Leslie Schiff Vincent meets up with Roberto, Reuben, Lou, and Leslie at the University of Minnesota to talk about their work on HIV-1, APOBEC proteins, measles virus, and teaching virology to undergraduates. Links for this episode: University of Minnesota virology timeline Revisiting HIV-1 lethal mutagenesis (Trends Micro) Exploiting HIV-1 drug repositioning (J Virol) 5-azaC induces HIV-1 lethal mutagenesis (J Virol) HIV-1 fitness and mutation rate (J Mol Biol) APOBEC3 mutagenesis in breast cancer (Nature) Restriction factors of HIV (J Biol Chem) Nectin-4 is epithelial measles receptor (Nature) Photographs of this episo...

2013 Highlights of ASH

Oncology Tube — Fri, 10 May 2013 18:51:13 +0100

Can't attend the ASH annual meeting in December? Attend one of the only official 2014 Highlights of ASH meetings that will be held in six locations across North America. These meetings will provide at... Author: ash Added: 05/10/2013 (Source: Oncology Tube)

Prostate Brachytherapy

Oncology Tube — Fri, 10 May 2013 16:10:49 +0100

is an excellent option for obese patients. Author: Chicago Prostate Ctr Added: 05/10/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

COMEDIAN H. ALAN SCOTT + SIBLINGS MATTER! - May 14,2013

The Stupid Cancer Show - Blog Talk Radio — Fri, 10 May 2013 03:15:00 +0100

GRACEcastUC102_Kidney_Dr. Bonomi on Targeted Therapy Toxicity Chemotherapy

Oncology Tube — Wed, 08 May 2013 17:20:49 +0100

http://cancerGRACE.org/... Dr. Phil Bonomi, from Rush University, discusses his perspective on side effects of targeted therapies as compared with standard chemotherapy for patients with lung cancer. Author: cancergrace Added: 05/08/2013 (Source: Oncology Tube)

Nouvel espoir pour les patients atteints de lymphome du manteau

Oncology Tube — Tue, 07 May 2013 19:01:26 +0100

Traitements du lymphome à cellules du manteau s'améliorent, offrant un nouvel espoir pour égaliser les patients les plus malades. Les nouveaux médicaments ont été discutés lors de la 9e Congrès Europé... Author: patientpower Added: 05/07/2013 (Source: Oncology Tube)

GRACEcast149_Pancreatic_Dr. Katz on Adjuvant Neoadjuvant Therapy Localized

Oncology Tube — Tue, 07 May 2013 16:35:26 +0100

http://cancerGRACE.org/... Dr. Matthew Katz, surgeon at MD Anderson Cancer Center, explains the rationale and introduces the current standards and some potential variants for systemic therapy in patie... Author: cancergrace Added: 05/07/2013 (Source: Oncology Tube)

GRACEcastUC101_Kidney_Dr. Pal on Surgery for Metastatic Kidney Cancer

Oncology Tube — Tue, 07 May 2013 16:32:20 +0100

http://cancerGRACE.org/... Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope Cancer Center in Duarte, CA, describes the role of surgery in the treatment of metastatic kidney cancer. Author: cancergrace Added: 05/07/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Memorial Sloan-Kettering Experience in Robotic-Assisted Minimally Invasive Thoracic Surgery

Oncology Tube — Tue, 07 May 2013 15:06:01 +0100

Thoracic surgeon Inderpal Sarkaria describes the applications of robotic surgery in esophagectomy and other thoracic procedures at Memorial Sloan-Kettering. Author: mskcc Added: 05/07/2013 (Source: Oncology Tube)

TRIPLE NEGATIVE BREAST CANCER - May 07,2013

The Stupid Cancer Show - Blog Talk Radio — Tue, 07 May 2013 00:00:00 +0100

Join us as we open the floodgates to expose Triple Negative Breast Cancer, a misunderstood variant of the disease that affects up to 25,000 women each year. We will be joined by Hayley Dinerman (Executive Director), Malaak Compton-Rock (Board Member) and Dr. Lisa Newman (Scientific Advisory Board) from the Triple Negative Breast Cancer Foundation. TNBC young adult survivor Rachel Pappas in the spotlight.triple negative breast cancer | malaak compton rock | young adult cancer | stupid cancer | womens health (Source: The Stupid Cancer Show - Blog Talk Radio)

GRACEcastUC100_Lung_Drs. Camidge and Langer on Which Patients Send Molecular Marker Testing

Oncology Tube — Mon, 06 May 2013 21:46:05 +0100

http://cancerGRACE.org/... Drs. Ross Camidge and Corey Langer describe which patients with advanced NSCLC they seek molecular marker testing on, and the particular markers they prioritize. Author: cancergrace Added: 05/06/2013 (Source: Oncology Tube)

GRACEcastUC099_CA-101_Dr. Einhorn on Widespread Availability of Mutation Testing

Oncology Tube — Mon, 06 May 2013 20:46:48 +0100

http://cancerGRACE.org/... Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, gives his view on more widespread availability of new mutation tests. Author: cancergrace Added: 05/06/2013 (Source: Oncology Tube)

GRACEcastUC098_Lung_Dr. Salgia on CollabRx Matching Mutations to Clinical Trials

Oncology Tube — Mon, 06 May 2013 17:36:35 +0100

http://cancerGRACE.org/... Dr. Ravi Salgia, University of Chicago, describes the CollabRx system, which matches patients with particular mutations to appropriate clinical trials. Author: cancergrace Added: 05/06/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

INSURANCE & HEALTHCARE LEGISLATION - Apr 23,2013

The Stupid Cancer Show - Blog Talk Radio — Sun, 05 May 2013 15:00:00 +0100

Down the rabbit hole again we go discussing the perils and pitfalls of the bureaucratic hot mess we call a healthcare system. Join experts Rebecca Nells (VP, Programs & Strategy, Cancer and Careers), Monica Fawzy, Esq. (COO, Navigating Cancer Survivorship) and Matthew Farber (Director, Public Policy, Association of Community Cancer Centers) for an epic roundtable debate. Survivor spotlight on Acute Myelogenous Leukemia survivor Jen Stewart.affordable care act obamacare | navigating cancer survivorship | public health policy | cancer and careers | stupid cancer (Source: The Stupid Cancer Show - Blog Talk Radio)

13-04-13 (6) Alimentazione ed effetti collaterali

Oncology Tube — Sat, 04 May 2013 02:12:10 +0100

6° Convegno Nazionale AIG, Bologna - Italy. Loris Pironi Responsabile del Centro Regionale di Riferimento per l'Insufficienza Intestinale Cronica, Dipartimento Ospedaliero di Malattie dell'Apparato ... Author: gistonline Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC097_Lung_Dr. Oxnard on Most Promising Targeted Therapy

Oncology Tube — Fri, 03 May 2013 19:27:50 +0100

http://cancerGRACE.org/... Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next ... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC096_Lung_Dr. Kelly on Continuing Treatment Exhaust Benefit

Oncology Tube — Fri, 03 May 2013 19:24:24 +0100

http://cancerGRACE.org/... Dr. Karen Kelly, of the University of California, Davis, provides her thoughts on whether to continue an effective treatment beyond 4-6 cycles in an effort to exhaust the po... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC095_Lung_Dr. Spigel on Pros and Cons of Molecular Testing

Oncology Tube — Fri, 03 May 2013 19:20:06 +0100

http://cancerGRACE.org/... David Spigel, Sarah Cannon Cancer Center, reviews how he discusses the potential advantages and disadvantages waiting on molecular marker results and sometimes seeking addit... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

GRACEcastUC094_Lung_Dr. Goldberg on how to Manage Acquire Resistance

Oncology Tube — Fri, 03 May 2013 19:11:58 +0100

http://cancerGRACE.org/... Dr. Sarah Goldberg, from Yale Cancer Center, offers her insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more mul... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC093_Lung_Dr. Sequist on Multiplex Next Generation Sequencing

Oncology Tube — Fri, 03 May 2013 19:05:19 +0100

http://cancerGRACE.org/... Dr. Lecia Sequist of Massachusetts General Hospital, discusses the concept of multiplex next generation sequencing and how it could change molecular oncology. Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC092_Lung_Dr. Juergens on Targeted Therapy Adjuvant Early Stage

Oncology Tube — Fri, 03 May 2013 19:01:07 +0100

http://cancerGRACE.org/... Dr. Rosalyn Juergens, McMaster University, addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with ... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC091_Lung_Repeat Biopsy Acquired Resistance

Oncology Tube — Fri, 03 May 2013 18:53:51 +0100

http://cancerGRACE.org/... Dr. Greg Riely, from Memorial Sloan-Kettering, reviews his thought process in recommending a repeat biopsy at initial diagnosis or after progression for patients with advanc... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC090_Lung_Widespread Availability of Mutation Testing

Oncology Tube — Fri, 03 May 2013 18:49:51 +0100

http://cancerGRACE.org/... Drs. Ross Camidge and Corey Langer give their views on more widespread availability of new mutation tests. Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

GRACEcastUC089_Kidney_Dr. Pal on Chemotherapy Role in Kidney Cancer Treatment

Oncology Tube — Fri, 03 May 2013 18:29:30 +0100

http://cancerGRACE.org/... Dr. Sumanta (Monty) Pal reviews the current role of chemotherapy in the treatment of kidney cancer. Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC088_Lung_Dr. Bonomi on Lung Cancer Targeted Therapies

Oncology Tube — Fri, 03 May 2013 18:24:14 +0100

http://cancerGRACE.org/... Dr. Phil Bonomi, from Rush University, provides his perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicab... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC087_Lung_Dr. Kelly on Targeted Therapy

Oncology Tube — Fri, 03 May 2013 18:18:35 +0100

http://cancerGRACE.org/... Dr. Karen Kelly of the University of California, Davis, provides her view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the ... Author: cancergrace Added: 05/03/2013 (Source: Oncology Tube)

Cure Cancer? Let's Rock and Roll!

Medscape Medscape Podcast — Fri, 03 May 2013 15:58:51 +0100

Dr. Bruce Cheson discusses the new and much-touted strategy to cure cancer via a ‘band’ of all-stars. (Source: Medscape Medscape Podcast)

New Lung Cancer Screening Offered At MD Anderson

Oncology Tube — Fri, 03 May 2013 15:40:05 +0100

Results from national clinical trial mobilizes a team of experts to develop Lung Cancer Screening Program. For appointment contact AskMDAnderson 877-MDA-6789 https://www2.mdanderson.org...... Author: mdanderson Added: 05/03/2013 (Source: Oncology Tube)

GRACEcastUC086_Lung_Dr. Spigel on Repeat Biopsy Molecular Testing

Oncology Tube — Thu, 02 May 2013 21:49:05 +0100

http://cancerGRACE.org/... Dr. David Spigel from Sarah Cannon Cancer Center in Nashville, TN expresses his practice pattern for patients with advanced non-small cell lung cancer who would need a repea... Author: cancergrace Added: 05/02/2013 (Source: Oncology Tube)

GRACEcastUC085_Lung_Dr. Goldberg Sampling Methods on Molecular Testing

Oncology Tube — Thu, 02 May 2013 21:44:24 +0100

http://cancerGRACE.org/... Dr. Sarah Goldberg from Yale Cancer Center describes the methods she uses to obtain tissue samples for molecular testing. Author: cancergrace Added: 05/02/2013 (Source: Oncology Tube)

Practice Makes Perfect -- and Lowers Mortality by 20%

Medscape Oncology — Wed, 01 May 2013 17:57:03 +0100

A Swedish study of patients with esophageal cancer who had esophagectomy indicated that surgeon volume affected prognosis, suggesting to Dr. David Kerr that some procedures should be centralized. (Source: Medscape Oncology)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Teaming Up Against Sarcoma

Oncology Tube — Tue, 30 Apr 2013 22:04:47 +0100

Drs. Darin Davidson and Robin Jones, sarcoma experts at the Seattle Cancer Care Alliance, discuss the importance of seeking treatment by a multidisciplinary team at a specialized center to provide the... Author: patientpower Added: 04/30/2013 (Source: Oncology Tube)

Improving a Breakthrough: Combination Therapies with JAK Inhibitors

Oncology Tube — Tue, 30 Apr 2013 22:03:54 +0100

JAK2 inhibitor therapies have been one of the most exciting recent breakthroughs for myelofibrosis. Researchers are now looking for ways to improve them further. Dr. Claire Harrison explains what is c... Author: patientpower Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-034_Lung-Cancer_Dr. Salgia on Acquired Resistance

Oncology Tube — Tue, 30 Apr 2013 21:51:39 +0100

GRACEcastUC-034_Lung-Video_Salgia_on_Acquired_Resistance Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-033_Lung-Cancer_Dr. Sandler on Molecular Testing Availability

Oncology Tube — Tue, 30 Apr 2013 21:45:49 +0100

Dr. Alan Sandler, Oregon Health and Science University, describes how he sees very specialized molecular testing for lung cancer becoming increasingly available to oncologists seeing patients in the c... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-032_Lung-Cancer_Dr. Bonomi on Maintenance Therapy

Oncology Tube — Tue, 30 Apr 2013 21:42:14 +0100

Dr. Phil Bonomi provides his views on the value of maintenance therapy for advanced non-small cell lung cancer and the various alternatives among maintenance therapies compared with a break from treat... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

GRACEcastUC-031_Lung-Cancer_Dr. Doebele on Targeted Therapies for Non-Small Cell Lung CancerSCLC Pops

Oncology Tube — Tue, 30 Apr 2013 21:39:34 +0100

Dr. Bob Doebele from the University of Colorado offers his perspective on whether targeted therapies will be able to applied to broader populations of patients with advanced NSCLC than those primarily... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-030_Kidney_Dr. Pal on Kidney Mass Evaluation

Oncology Tube — Tue, 30 Apr 2013 21:36:15 +0100

Dr. Sumanta (Monty) Pal of City of Hope Cancer Center in Duarte, CA reviews a recommended approach to the workup of a kidney mass suspected to be a cancer. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-029_Lung-Cancer_Drs. Camidge Langer on Who to Recommend Repeat Biopsy

Oncology Tube — Tue, 30 Apr 2013 21:16:31 +0100

Drs. Ross Camidge and Corey Langer discuss which patients with advanced NSCLC they would recommend should have a repeat biopsy if their initial tissue sample doesn't have sufficient tissue for molecul... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-028_Lung-Cancer_Dr. Goldberg on Pros & Cons of Molecular Testing

Oncology Tube — Tue, 30 Apr 2013 21:12:31 +0100

Dr. Sarah Goldberg reviews how she discusses the potential advantages and disadvantages waiting on molecular marker results and sometimes seeking additional tissue in patients with advanced NSCLC. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-025_Lung-Cancer_Acquired Resistance Targeted Therapies

Oncology Tube — Tue, 30 Apr 2013 21:09:15 +0100

Dr. Greg Riely from Memorial Sloan-Kettering reviews strategies for managing acquired resistance to EGFR inhibitors and other targeted therapies in advanced non-small cell lung cancer. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

GRACEcastUC-027_Lung-Cancer_What Molecular Markers for Advanced Non-Small Cell Lung Cancer

Oncology Tube — Tue, 30 Apr 2013 21:08:52 +0100

Dr. Karen Kelly describes her thought process on which molecular markers are those clearly indicated for testing in patients with advanced NSCLC, as well as whether smoking status factors into her app... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-026_Lung-Cancer_Molecular Marker Info for Early Non-Small Cell Lung Cancer

Oncology Tube — Tue, 30 Apr 2013 21:05:34 +0100

Dr. Heather Wakelee from Stanford University discusses the open question of whether patients with resectable or locally advanced NSCLC should have testing for molecular markers, as well as how we migh... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-023_Lung-Cancer_Molecular Marker Testing in NSCLC

Oncology Tube — Tue, 30 Apr 2013 20:59:34 +0100

Dr. Lecia Sequist describes the state of the art and her view of current best practices on molecular testing for advanced non-small cell lung cancer. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-022_Lung-Cancer_What is an Inherited T790M EGFR Mutation

Oncology Tube — Tue, 30 Apr 2013 20:56:11 +0100

Dr. Geoffrey Oxnard describes the new finding of individuals with an inherited T790M mutation in the EGFR gene, the unclear significance of it, and a study being conducted to learn more about it. Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

GRACEcastUC-020_Lung-Cancer_How to Approach Rare EGFR Mutation

Oncology Tube — Tue, 30 Apr 2013 20:51:23 +0100

Dr. Jack West describes recent information on the probability that someone with a rare EGFR mutation on exon 20, rather than a more common "activating" mutations on exon 19 or 21, will benef... Author: cancergrace Added: 04/30/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Immunizing Kids Who Have Cancer

Medscape Pediatrics Podcast — Mon, 29 Apr 2013 14:31:16 +0100

Vaccine-preventable disease is a serious concern for children with cancer. Can they be safely vaccinated? (Source: Medscape Pediatrics Podcast)

How Significant is a JAK2 Inhibitor as a Treatment for Myelofibrosis?

Oncology Tube — Fri, 26 Apr 2013 14:11:51 +0100

There's one approved JAK2 inhibitor medicine and more coming. While they are not a cure for myelofibrosis, in the opinion of a leading researcher, Dr. Srdan Verstovsek from MD Anderson Cancer, there a... Author: patientpower Added: 04/26/2013 (Source: Oncology Tube)

Does Anemia or Low Platelets Preclude the Use of an Approved JAK2 Inhibitor?

Oncology Tube — Fri, 26 Apr 2013 14:10:13 +0100

Anemia, low red cell count, and low platelets can be worrisome for patients with myelofibrosis and their doctors. It can happen when a new JAK2 inhibitor medicine is used. But in the opinion of a lead... Author: patientpower Added: 04/26/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

An Oncology Consult -- With a Computer?

Medscape Oncology — Thu, 25 Apr 2013 16:51:57 +0100

Dr. Mark Kris reports on the new wave of cognitive computing, made famous by IBM's Watson, that will offer in-office consultation to support decision-making in the treatment of patients with cancer. (Source: Medscape Oncology)

Sagar Lonial, MD - Meeting Clinical Challenges in Myeloma: A Roadmap to Improved Patient Care

PeerView CME/CE Audio Podcast - Oncology — Wed, 24 Apr 2013 18:25:49 +0100

Meeting Clinical Challenges in Myeloma: A Roadmap to Improved Patient Care (Source: PeerView CME/CE Audio Podcast - Oncology)

Febrile Neutropenia

Podmedics - Medical Podcasts — Wed, 24 Apr 2013 11:00:00 +0100

Dr Mohammed reviews this important oncological emergency (Source: Podmedics - Medical Podcasts)

Ambitious Directions for Prostate Cancer Research

Oncology Tube — Tue, 23 Apr 2013 02:08:21 +0100

Advancements in research tools and new drug treatments are making it an exciting time for developments in prostate cancer research. Dr. Joshi Alumkal from Oregon Health and Science University discusse... Author: patientpower Added: 04/22/2013 (Source: Oncology Tube)

2013 OncPrac Summit: Michael Postow on immuno- and targeted therapies for melanoma

Oncology Tube — Mon, 22 Apr 2013 23:16:23 +0100

Dr. Jame Abraham, an Editor on COMMUNITY ONCOLOGY, speaks to Dr. Michael Postow of the Memorial Sloan-Kettering Cancer Clinic about new immuno- and targeted therapies for the treatment of melanoma and... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

2013 OncPrac Summit: Dr. Geogre Kim on GI and Colon Cancers

Oncology Tube — Mon, 22 Apr 2013 23:15:49 +0100

OncChat from the 2013 Oncology Practice Summit, a conference hosted by COMMUNITY ONCOLOGY, THE JOURNAL OF SUPPORTIVE ONCOLOGY, and THE ONCOLOGY REPORT, March 21-23, 2013 in Las Vegas. Dr Jame Abraham,... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

2013 OncPrac Summit: Dr. Jorge Cortes on prognostic factors in Chronic Lymphocytic Leukemia

Oncology Tube — Mon, 22 Apr 2013 23:14:38 +0100

Here at the Oncology Practice Summit in Las Vegas, we had the opportunity to speak with Dr. Jorges Cortes, Deputy Chair of the Department of Leukemia at the University of Texas MD Anderson Cancer Cent... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

2013 OncPrac Summit: Corey Langer on managing NSCLC

Oncology Tube — Mon, 22 Apr 2013 23:13:14 +0100

Which lung cancer patients are eligible for bevacizumab therapy? What about maintenance therapy in this population? What's the latest on erlotinib therapy for EGFR-mutated patients? Find the answers t... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

2013 OncPrac Summit: Nicholas Vogelzang on how he treats metastic prostate cancer

Oncology Tube — Mon, 22 Apr 2013 23:12:10 +0100

Dr. Nicholas Vogelzang talks to Dr. David Henry, Editor in Chief of COMMUNITY ONCOLOGY, about how he treats patients with metastatic prostate cancer, given the new agents that are now available, and g... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

Combination myeloma therapy almost doubles PFS

Oncology Tube — Mon, 22 Apr 2013 23:10:55 +0100

Community Oncology Editor Dr. David Henry spoke with Dr. Kenneth Anderson at the Oncology Practice Summit in Las Vegas about the antibody elotuzumab in the treatment of relapsed or refractory multiple... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

HPV Epidemic Changes Head & Neck Cancer Pathophysiology

Oncology Tube — Mon, 22 Apr 2013 23:08:49 +0100

Dr. Ezra Cohen the from the University of Chicago speaks with Dr. Debra Patt, Oncology Practice Summit Session Chair, regarding HPV and its effect on the pathophysiology and treatment of head and neck... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

Ki-67 shows proven clinical utility as a predictive clincal biomarkers for breast cancer

Oncology Tube — Mon, 22 Apr 2013 23:06:17 +0100

Community Oncology Founding Editor Dr. Lee Schwartzberg, spoke with Dr. Joyce O'Shaughnessy at the Oncology Practice Summit in Las Vegas about emerging molecular biomarkers in breast cancer and shares... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

News from the 2012 ASCO Annual Meeting: Monday, June 4, 2012 (Dr. Nicholas Vogelzang)

Oncology Tube — Mon, 22 Apr 2013 23:01:23 +0100

talks about metastastic breast cancer treatment. Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

The Evolution of a Promising Cancer Drug Called CBLB502

Oncology Tube — Mon, 22 Apr 2013 22:54:02 +0100

Andrei Gudkov, PhD, DSCi, Senior Vice President of Basic Science and The Garman Family Chair in Cell Stress Biology at Roswell Park, explains the research behind the creation of CBLB502, a drug that h... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

Diagnosing and Staging Cancers Using Endoscopic Ultrasound (EUS)

Oncology Tube — Mon, 22 Apr 2013 22:52:46 +0100

If your doctor wants you to have an upper endoscopy, do you know what to expect? Do you know what is meant by endoscopic ultrasound (EUS)? Dr. Andrew Bain, Gastroenterologist and Assistant Professor o... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

PIVOT Prostate Cancer Study Should Empower Men to Make Informed Decisions

Oncology Tube — Mon, 22 Apr 2013 22:51:35 +0100

An important study published in the New England Journal of Medicine (NEJM) addresses the use of the prostate-specific antigen test, or PSA test, for early detection and the challenges regarding proper... Author: feeds Added: 04/22/2013 (Source: Oncology Tube)

Can BRCA Expression Predict Response to Chemotherapy?

Medscape Pathology and Laboratory Medicine Podcast — Mon, 22 Apr 2013 18:12:31 +0100

Dr. Maurie Markman reviews a recent paper looking at whether differences in BRCA expression might predict response to IP vs IV chemotherapy in patients with ovarian cancer. (Source: Medscape Pathology and Laboratory Medicine Podcast)

Smile More, Live Better

Oncology Tube — Fri, 19 Apr 2013 20:09:28 +0100

What can smiling do for your health? Smiling not only reduces stress, but radiates positive emotion to those around you. Patient Power contributor Christopher Springmann discusses the research and enc... Author: patientpower Added: 04/19/2013 (Source: Oncology Tube)

#187: Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal?

Radio TheHeart.org — Fri, 19 Apr 2013 16:55:00 +0100

Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal o (Source: Radio TheHeart.org)

Surgery Beats Radiation in Localized PC? Not so Fast…

Medscape General Surgery Podcast — Fri, 19 Apr 2013 16:46:54 +0100

Dr. Gerald Chodak discusses the limitations of a new study that's being used to promote surgery over radiation in localized prostate cancer. (Source: Medscape General Surgery Podcast)

'Get Off Your Bottom'

Medscape Oncology — Fri, 19 Apr 2013 16:09:54 +0100

Patients who sit for more than 6 hours a day have a 36% increased risk for all-cause mortality -- study results that prompt Dr. David Kerr to exhort docs and patients alike to get off the couch. (Source: Medscape Oncology)

A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy f

Oncology Tube — Fri, 19 Apr 2013 12:34:54 +0100

Gynecologic oncologist Dennis Chi describes a clinical trial evaluating secondary cytoreduction with and without HIPEC for various malignancies. Author: mskcc Added: 04/19/2013 (Source: Oncology Tube)

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Topol on the Cancer Clinic of the Future

Medscape Emergency Medicine Podcast — Wed, 17 Apr 2013 18:22:32 +0100

Dr. Eric Topol explains how the cancer clinic of the future will look. (Source: Medscape Emergency Medicine Podcast)

Controversies in NSCLC: Do We Have Consensus?

Medscape Pathology and Laboratory Medicine Podcast — Wed, 17 Apr 2013 18:15:10 +0100

Dr. Mark Kris reports on the current status of such NSCLC controversies as maintenance therapy and mutation testing, as discussed at the 2013 meeting on Targeted Therapies in Lung Cancer. (Source: Medscape Pathology and Laboratory Medicine Podcast)

INSURANCE & HEALTHCARE LEGISLATION - Apr 23,2013

The Stupid Cancer Show - Blog Talk Radio — Wed, 17 Apr 2013 15:15:00 +0100